<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Yahoo!ファイナンス掲示板 - ニューアムステルダム・ファーマ・カンパニー</title><link>https://finance.yahoo.co.jp/cm/message/1160009528/a6f51549ba3c27e98ebc0ccdbcfc6a5b</link><lastBuildDate>Wed, 14 Jan 2026 17:07:00 +0900</lastBuildDate><description>Yahoo!ファイナンス掲示板</description><language>ja</language><copyright>© LY Corporation</copyright><image><title>Yahoo!ファイナンス掲示板</title><width>28</width><height>28</height><link>https://finance.yahoo.co.jp/cm/</link><url>//s.yimg.jp/images/sicons/textream28.gif</url></image><item><title>2026 Expected (&amp;hellip;</title><link>https://finance.yahoo.co.jp/cm/message/1160009528/a6f51549ba3c27e98ebc0ccdbcfc6a5b?comment=6</link><description><![CDATA[2026 Expected (Summary) &lt;br /&gt;
&lt;br /&gt;
Regulatory / Commercial&lt;br /&gt;
 &bull; EMA approval expected in 2H &hellip;]]></description><author>M</author><pubDate>Wed, 14 Jan 2026 17:07:00 +0900</pubDate><guid isPermaLink="true">https://finance.yahoo.co.jp/cm/message/1160009528/a6f51549ba3c27e98ebc0ccdbcfc6a5b?comment=6</guid></item><item><title>Form 8-K（Januar&amp;hellip;</title><link>https://finance.yahoo.co.jp/cm/message/1160009528/a6f51549ba3c27e98ebc0ccdbcfc6a5b?comment=5</link><description><![CDATA[Form 8-K&#xff08;January 9, 2026&#xff09;&lt;br /&gt;
ongoing Phase3&lt;br /&gt;
&#x30fb;PREVAIL study&#xff08;NCT05202509&#xff09;&lt;br /&gt;
&#x3000;Primary Com&hellip;]]></description><author>M</author><pubDate>Sat, 10 Jan 2026 23:14:22 +0900</pubDate><guid isPermaLink="true">https://finance.yahoo.co.jp/cm/message/1160009528/a6f51549ba3c27e98ebc0ccdbcfc6a5b?comment=5</guid></item><item><title>obicetrapib&apos;s u&amp;hellip;</title><link>https://finance.yahoo.co.jp/cm/message/1160009528/a6f51549ba3c27e98ebc0ccdbcfc6a5b?comment=3</link><description><![CDATA[obicetrapib&apos;s ultimate value will be determined by PREVAIL Study.&lt;br /&gt;
&lt;br /&gt;
PREVAIL Study&#xff08;NCT052&hellip;]]></description><author>M</author><pubDate>Sat, 03 Jan 2026 21:08:01 +0900</pubDate><guid isPermaLink="true">https://finance.yahoo.co.jp/cm/message/1160009528/a6f51549ba3c27e98ebc0ccdbcfc6a5b?comment=3</guid></item><item><title>NewAmsterdam Pharma Company N V</title><link>https://finance.yahoo.co.jp/cm/message/1160009528/a6f51549ba3c27e98ebc0ccdbcfc6a5b?comment=1</link><description><![CDATA[NewAmsterdam Pharma Company N V&#x306b;&#x3064;&#x3044;&#x3066;&#x8a71;&#x3057;&#x5408;&#x3046;&#x30b9;&#x30ec;&#x30c3;&#x30c9;&#x3067;&#x3059;&#x3002;&lt;br /&gt;
&#x30b9;&#x30ec;&#x30c3;&#x30c9;&#x306e;&#x30c6;&#x30fc;&#x30de;&#x3068;&#x7121;&#x95a2;&#x4fc2;&#x306e;&#x30b3;&#x30e1;&#x30f3;&#x30c8;&#x3001;&#x3082;&#x3057;&#x304f;&#x306f;&#x4ed6;&#x306b;&#x3075;&#x3055;&#x308f;&#x3057;&#x3044;&#x30b9;&#x30ec;&#x30c3;&#x30c9;&#x304c;&#x3042;&#x308b;&#x30b3;&#x30e1;&#x30f3;&#x30c8;&#x306f;&#x524a;&#x9664;&#x3055;&#x308c;&#x308b;&hellip;]]></description><author>Yahoo!ファイナンス掲示板</author><pubDate>Sun, 27 Nov 2022 02:00:08 +0900</pubDate><guid isPermaLink="true">https://finance.yahoo.co.jp/cm/message/1160009528/a6f51549ba3c27e98ebc0ccdbcfc6a5b?comment=1</guid></item></channel></rss>